SCHEMBL7044301

SCHEMBL7044301

COc1ccc(CC(=O)c2cc(O)c(O)c([N+](=O)[O-])c2)cc1OC

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.54
NPC1 O15118 3/20 0.54
HTT P42858 2/20 0.54
MAPT P10636 3/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
GAA P10253 2/20 0.53
HPGD P15428 1/20 0.53
SMN1; SMN2 Q16637 4/20 0.51
CYP3A4 P08684 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP1A2 P05177 1/20 0.48
RAB9A P51151 2/20 0.48
COMT P21964 2/20 0.47
ABCC3 O15438 1/20 0.47
ABCC4 O15439 1/20 0.47
NR1I2 O75469 1/20 0.47
ABCB11 O95342 1/20 0.47
TTR P02766 1/20 0.47
NR3C1 P04150 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7046272 0.81 TTR (0.53) LMNANPC1MAPTMEN1KMT2A
SCHEMBL7045653 0.81 TTR (0.67) LMNANPC1MAPTMEN1KMT2A
SCHEMBL7046444 0.81 TTR (0.51) LMNANPC1MAPTMEN1KMT2A
SCHEMBL7048659 0.79 TTR (0.52) LMNAMAPTMEN1KMT2AGAA
SCHEMBL7046543 0.79 TTR (0.58) LMNANPC1MAPTMEN1KMT2A
Nebicapone SCHEMBL29379610 0.78 TTR (0.56) LMNAMAPTMEN1KMT2AHPGD
Nebicapone SCHEMBL132167 0.78 TTR (0.56) LMNAMAPTMEN1KMT2AHPGD
SCHEMBL7048078 0.78 TTR (0.52) LMNANPC1MAPTMEN1KMT2A
SCHEMBL7046913 0.78 TTR (0.50) LMNANPC1MAPTMEN1KMT2A
SCHEMBL7046492 0.78 TTR (0.55) LMNAMAPTMEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1010688-B1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them PORTELA & CA SA (PT) 2003-04-09 EP disclosed
US-6512136-B1 Hypotensive, antiedemic agents; gastrointestinal disorders; Parkinson*s disease treatment PORTELA & C.A., S.A. (PT) 2003-01-28 US disclosed
EP-1010688-A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them Portela & Ca., S.A. (PT) 2000-06-21 EP disclosed